Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship.

ABSTRACT: Despite the importance of chemotherapy-associated adverse events in oncology practice and the broad range of interventions available to mitigate them, limited systematic efforts have been made to identify, critically appraise and summarize the totality of evidence on the effectiveness of these interventions. Herein, we review the most common long-term (continued beyond treatment) and late or delayed (following treatment) adverse events associated with chemotherapy and other anticancer treatments that pose major threats in terms of survival, quality of life and continuation of optimal therapy. These adverse effects often emerge during and continue beyond the course of therapy or arise among survivors in the months and years following treatment. For each of these adverse effects, we discuss

SUBMITTER: Lustberg MB 

PROVIDER: S-EPMC10211308 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature